Gold price surges to fresh all-time high as Trump trade war rattles markets
Gold prices have surged to a new record high with investors flocking to safer assets as US President Donald Trump's tariff plans continue to spark volatility in the world's financial markets.
The precious metal surpassed 3,200 US dollars (£2,442) per ounce on Friday morning – its highest ever price.
Analysts said the spike reflects investors searching for so-called 'safe haven' assets.
These tend to carry less risk than other investments, such as stocks and shares, and often outperform financial markets during periods of turbulence.
Richard Hunter, head of markets at Interactive Investor, said investors 'headed to the door once more in search of haven assets' following a 'brief relief rally' in equity markets.
UK and European stocks surged higher on Thursday as traders welcomed Mr Trump's decision to push back the introduction of some US tariffs by 90 days.
But concerns over the impact of new and higher import taxes remain prominent, while the prospect of all-out trade war between the US and China has intensified.
The Royal Mint, which is the UK's official maker of British coins, said it had seen a jump in demand for gold coins and bars.
Toby Osborne, the company's head of wealth management, said: 'Amid escalating trade tensions between the US and China, we've seen more customers purchasing physical gold such as coins and bars from the Royal Mint website.
'With markets facing uncertainty, gold remains a trusted store of value.'
He added that silver was also 'gaining popularity, serving as an accessible entry point for investors' while gold trading hit all-time highs.
Pawnbroker and retailer Ramsdens earlier this week said higher gold prices, and an increase in the weight of gold purchased by buyers, had helped drive a 50% surge in profits for its precious metals division.
Analysts also flagged that some currencies had been boosted amid the turmoil.
Investment has been flowing 'towards currencies such as the Swiss franc and the yen', Mr Hunter said, while the US dollar has slumped in value in recent days.
Meanwhile, UK and European stock markets opened higher on Friday, but gains were swiftly reversed as tensions between China and the US continued to ramp up.
London's FTSE 100 was in negative territory by Friday morning and losses were growing for the Dax in Frankfurt and the Cac 40 in Paris.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
The market has a big opportunity to tell Trump what it thinks about his big tax bill
A government bond auction this week will test what investors think of the GOP tax bill. The Treasury will sell $22 billion of 30-year bonds on Thursday, and demand will be closely watched. Bond investors have been reacting to developments around the bill in recent weeks. US Treasury auctions happen all the time, and they're usually unremarkable for markets. But this week's offering of 30-year government bonds will take on heightened importance. That's because it could represent an important test of what investors think about Donald Trump's so-called "Big Beautiful" tax bill. Yields on government bonds have risen in recent weeks as bond traders have dumped the fixed-income securities. The logic of their trading activity is straightforward: Amid concerns that the tax bill will further inflate a sizable federal deficit — and with so much uncertainty swirling around Trump policies overall — the appeal of holding long-dated government debt has taken a hit. This embedded content is not available in your region. The slate of bond auctions scheduled for this week is heavy, with $58 billion of three-year notes to be sold on Tuesday and $59 billion of 10-year bonds up for auction on Wednesday. But amid the deluge of supply, investors will likely be watching the $22 billion sale of 30-year debt the closest. The auction happens at a time when the safety and soundness of long-dated government bonds are being scrutinized more than ever, and not just in the US. Governments around the world have seen their debt costs spiral higher this year as bond investors question the wisdom of lending to countries running huge deficits and fueling their spending sprees with more and more debt. In the US, the concern is that the federal government — already running a steep budget deficit — is laying the groundwork for more issues down the road if lawmakers pass the Republicans' sweeping spending and tax bill. The Congressional Budget Office estimated last week that the spending bill would add $2.4 trillion to the deficit over a decade. Economists and analysts say the worry is that high deficits and heavy borrowing could lead to higher inflation, less growth, and fiscal instability — and it's got the so-called bond vigilantes on high alert already. The 30-year Treasury yield was about 4.95% on Monday, having edged down in recent weeks after touching 5.1% last month, which was the highest level since 2008. Scott Buchta, the head of fixed income strategy at Brean Capital, told Business Insider that 5% could be a sweet spot for the coming auction, drawing in long-duration investors that might be monitoring the deficit developments with unease. "It's going to be interesting. It'll depend on where the 30-year is trading going into the auction," Buchta said. "My gut is that there will be more demand at 5% than in the mid-to-high 4s." While the deficit is definitely on the radar, Buchta said that future auctions of 30-year bonds could be even more important because the market will have more clarity on the state of the tax bill. Markets already got a taste of what could happen this week back in May, when a weak 20-year bond auction in the early days of the debate over the tax bill sent stocks tumbling and fueled concerns of a buyers' strike in longer-dated US bonds. The concern among investors is that sputtering demand for long-dated Treasurys could reignite the "sell America" narrative that's waxed and waned in 2025 amid fears over tariffs, inflation, and, now, the deficit. "Any sign of diminished investor appetite could be interpreted as a reason to reallocate assets away from the US — while healthy demand might see the dollar gain as fears of a buyer's strike abate and the "de-dollarisation" theme loses some of its impetus," Karl Schamotta, chief market strategist at Corpay, wrote on Monday. This week's bond auctions are also big events for the stock market. Rising yields are a headwind for stock prices, and long-dated bond yields at or above 5% have tanked stocks in recent years. "The line in the sand is probably around 5% on the 30-year, and above that, you might see investors get more concerned, especially since the market has rallied so much recently," Paul Hickey, the co-founder of Bespoke Investment Management, told BI. With stocks hovering close to record highs, it might not take much to spark a pullback. If bond investors balk at this week's auctions over fears about the tax bill, expect the sense of complacency that's settled over markets to be quickly dispelled. "Bond auctions could shake markets out of this sense of relative calm," Corpay's Schamotta said. "Long-dated bond yields have been rising for months, with growing inflation worries, fiscal deficit fears, concerns about weakening demand from foreign real-money investors, and political uncertainty combining to widen risk premia across the curve." Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
an hour ago
- Business Upturn
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease
Seongnam-si, South Korea and Abu Dhabi, UAE, June 09, 2025 (GLOBE NEWSWIRE) — AriBio Co., Ltd. ('AriBio'), a South Korean biopharmaceutical company specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a global life sciences company based in Abu Dhabi (collectively 'Arcera'), today announced the signing of exclusive licensing and commercialization, and supply agreements for AR1001, an investigational oral therapy for Alzheimer's disease. Under the terms of the agreements, Arcera will have exclusive rights to commercialize AR1001 in its key markets, including Latin America, the Middle East, Southern Africa, Ukraine and select Eurasian countries. AriBio will be responsible for manufacturing and supplying the product. The total deal value is estimated at USD 600 million across the development, launch and commercialization period, contingent upon the achievement of certain milestones. Advertisement AR1001 is a novel, disease-modifying, once-daily oral phosphodiesterase-5 (PDE5) inhibitor currently being studied in a global Phase 3 clinical trial (POLARIS-AD) for the treatment of early-stage Alzheimer's disease. The enrollment target for the Phase 3 trial has been reached, and the topline results are expected in the first half of 2026. Facilitated by the Korea Development Bank (KDB) and aligned with the Korean government's policy to foster the biohealth industry, this collaboration represents a significant step forward to enhance the global competitiveness of Korea's pharmaceutical and biotech industry. 'This partnership with Arcera marks a significant milestone in our mission to bring innovative treatments to patients worldwide,' said Jai Jun Choung, CEO of AriBio. 'Arcera's strong commercial capabilities and deep understanding of the high-growth markets make them an ideal partner to advance AR1001 in these important regions.' 'We are excited to enter into this collaboration with AriBio, which will provide access to AR1001, a novel treatment, for patients across these countries,' said Isabel Afonso, CEO of Arcera. 'This agreement aligns with our strategy to expand our neuroscience portfolio and reinforces our commitment to providing access to novel therapies in regions with significant unmet medical needs.' The agreement underscores both companies' dedication to addressing unmet medical needs in neurodegenerative diseases and enhancing patient access to innovative therapies globally. This deal follows the Memorandum of Understanding signed between AriBio and Arcera in March 2025, where both parties agreed to strengthen their partnership by actively exploring strategic investments, and advancing joint research and development based on shared interests. ENDS About AriBio Co., Ltd. Founded in 2010, AriBio is a clinical-stage biopharmaceutical company headquartered in South Korea, with offices located in the United States to manage global clinical operations and regulatory affairs. The company focuses on the development of novel therapies for neurodegenerative diseases, including Alzheimer's disease. AriBio continues to expand its partnerships to accelerate the development and delivery of life-changing treatments to patients worldwide. About Arcera Arcera is a global life sciences company, headquartered in Abu Dhabi. Arcera develops, manufactures, and commercializes a broad range of high-quality proven and innovative medicines in key international markets. Its portfolio exceeds 2,000 medicines covering wide therapeutic areas which reach patients in ninety countries in four continents, backed by manufacturing and packing sites across the world. Arcera was established by the sovereign wealth fund, ADQ to realize Abu Dhabi's ambition as a global leader in innovative and sustainable healthcare. To learn more about Arcera, visit Attachment AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hamilton Spectator
an hour ago
- Hamilton Spectator
Elbows-up tourism surge could see sector ‘eke out' a gain even as Americans stay away
From the front desk of Hotel Bedford in Goderich, Ont., Lynda Cross welcomes guests from regions ranging from southern Ontario to the South Pacific. 'A lot of them come from Toronto,' said the manager, standing just inside the Romanesque arches of the 129-year-old establishment. 'Just lately, we've had a few groups come from Australia' — a first, she said. But one crop of tourists has been conspicuously absent this year: Americans. 'May and June have been slow.' A groundswell of economic patriotism has stoked curiosity in Canadian destinations, fuelling a domestic bookings surge as travellers turn away from cross-border trips. But a drop in American visitors north of the border and fears that many Canadians will simply stay home to save money has many wondering whether homegrown and overseas tourism can make up for the stateside decline. Canadian vacationers' boycotting the U.S. could net this country's tourism sector up to $8.8 billion in extra business this year as travellers explore spots closer to home, according to a report from the Conference Board of Canada. An April survey on travel intentions prompted the group to predict a windfall despite fewer border crossings this year by American tourists — Canada's largest source of inbound travellers by far. The number of Americans who visited Canada by car fell nearly 11 per cent in April compared with the same month last year, the third straight month of year-over-year decreases, according to Statistics Canada. While trip numbers for Canadians heading to the U.S. have fallen off far more steeply as part of a backlash against U.S. President Donald Trump's tariffs and '51st state' threats, Americans' more moderate pullback owes to factors ranging from pinched pocketbooks to fears of feeling unwelcome to angst over the border crossing on the drive home. The American retreat could hit communities that hug the border especially hard. 'Border towns that have tended to experience the shorter, more frequent back-and-forth visits — those are going to be communities that are going to be more heavily affected,' said Andrew Siegwart, who heads the Tourism Industry Association of Ontario. Duty-free stores have seen their revenue drop by 60 to 80 per cent in the last few months, according to an association representing 32 of the mostly mom-and-pop shops. Whether overseas travellers can make up for much of the lower American traffic across the country is questionable. Visitor volume from China, previously a key source of tourists, sat at 40 per cent of 2019 levels last year amid ongoing restrictions on group travel to Canada, according to Destination Canada. The federal government imposed new visa requirements on Mexican visitors last year, making it harder for tourists from that country to come. 'Travel from India has also been down for a number of reasons. So it's going to take some time,' said Siegwart. However, many America-averse Canadians are spending their travel budget in their own backyards. More than half of respondents to a survey released Monday by Ontario's travel regulator said they were more likely to make excursions closer to home, with the trend holding across all age groups. 'It could be a year where we manage to stay on par with last year, or maybe even eke out a little bit of a gain,' said Siegwart. But he acknowledged the hurdle of consumer anxiety over the economy. 'I'm cautiously optimistic,' he said, 'but it's too early to tell.' Summer bookings were either the same or higher than last year at two out of three businesses surveyed by the association in a poll released last month. John Steele, who owns seven hotels in Newfoundland and Labrador and one in Fredericton, said visitor levels look 'pretty good' at most of his properties but softer in Gander. New direct flights to St. John's from London and Paris have made it easier for international travellers to come from away. 'Air access seems to be improving for us. That's a big thing for us,' Steele said. At Okanagan Wine Country Tours in British Columbia, bookings from Europe and the United Kingdom have risen about 20 per cent year-over-year, said partner and manager Marsha Morrish. 'The traffic from Quebec is up substantially,' she added. Americans are more tepid — even those who do head north. 'They did email me to do a bit of a temperature check on how Canadians were feeling about Americans visiting,' Morrish said, referring to a Colorado couple coming up to sample Pinot Gris. While there's a chance American tourist numbers could surge, it's unlikely to happen this year, Siegwart suggested — including for corporate gatherings. 'Some convention centres, both in Ontario and across the country, have seen some drops in American conference bookings.' Much of it has to do with personal safety and security, as some workers worry about how they'll be treated at the border. 'Depending on your immigration status, depending on if you're a member of an LGBTQIA community, if your gender markers or identities on your passports are different than your gender expression — all sorts of things like that are really coming into play,' Siegwart said. 'My colleagues south of the border are a little more cautious in how they plan things because of the unpredictable way in which their administration is conducting business.' On the flip side, there's more interest from corporate event planners in Europe 'who still want to come to North America but see Canada as a safer bet.' Some Americans remain undeterred though. 'I've seen way more people from the States this year,' said Wendy Mooney, owner of Country Hideaway RV Campground, which sits barely a kilometre from the border in the B.C.'s West Kootenay region. 'Some people just fly by the seat of their pants.' This report by The Canadian Press was first published June 9, 2025.
